Rotrosen, John

Cingulate-Precuneus Interactions: A New Locus of Dysfunction in Adult Attention-Deficit/Hyperactivity Disorder

Castellanos, F. X., Margulies, D. S., Kelly, C., Uddin, L. Q., Ghaffari, M., Kirsch, A., Shaw, D., Shehzad, Z., Di Martino, A., Biswal, B., et al. (2008) · Biological Psychiatry

Attention Deficit Hyperactivity DisorderFunctional Brain Connectivity Studies

Cited by 854

Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature

WILENS, T. E., ADLER, L. A., ADAMS, J., SGAMBATI, S., ROTROSEN, J., SAWTELLE, R., UTZINGER, L., & FUSILLO, S. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderNeuroethics, Human Enhancement, Biomedical Innovations

Cited by 824

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial

Bogenschutz, M. P., Ross, S., Bhatt, S., Baron, T., Forcehimes, A. A., Laska, E., Mennenga, S. E., O’Donnell, K., Owens, L. T., Podrebarac, S., et al. (2022) · JAMA Psychiatry

Psychedelics and Drug StudiesSubstance Abuse Treatment and Outcomes

Cited by 711

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Lee, J. D., Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., Farkas, S., Fishman, M., Gauthier, P., Hodgkins, C. C., et al. (2018) · The Lancet

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 700

Network homogeneity reveals decreased integrity of default-mode network in ADHD

Uddin, L. Q., Kelly, A. M. C., Biswal, B. B., Margulies, D. S., Shehzad, Z., Shaw, D., Ghaffari, M., Rotrosen, J., Adler, L. A., Castellanos, F. X., et al. (2008) · Journal of Neuroscience Methods

Functional Brain Connectivity StudiesAttention Deficit Hyperactivity Disorder

Cited by 452

Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia

Angrist, B., Rotrosen, J., & Gershon, S. (1980) · Psychopharmacology

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 344

Extended-release naltrexone to prevent opioid relapse in criminal justice offenders

Lee, J. D., Friedmann, P. D., Kinlock, T. W., Nunes, E. V., Boney, T. Y., Hoskinson, R. A., Wilson, D., McDonald, R., Rotrosen, J., Gourevitch, M. N., et al. (2016) · New England Journal of Medicine

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 315

Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff

McNeely, J., Kumar, P. C., Rieckmann, T., Sedlander, E., Farkas, S., Chollak, C., Kannry, J. L., Vega, A., Waite, E. A., Peccoralo, L. A., et al. (2018) · Addiction Science & Clinical Practice

Substance Abuse Treatment and OutcomesHealth Policy Implementation Science

Cited by 303

Volumetric Measure of the Frontal and Temporal Lobe Regions in Schizophrenia: Relationship to Negative Symptoms

Sanfilipo, M., Lafargue, T., Rusinek, H., Arena, L., Loneragan, C., Lautin, A., Feiner, D., Rotrosen, J., & Wolkin, A. (2000) · Archives of General Psychiatry

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 281

Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography

Wolkin, A., Angrist, B., Wolf, A., Brodie, J., Wolkin, B., Jaeger, J., Cancro, R., & Rotrosen, J. (1987) · Psychopharmacology

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 100

Drug Addiction and Stress-Response Genetic Variability: Association Study in African Americans: Stress-Response Genes and Drug Addiction

Levran, O., Randesi, M., Li, Y., Rotrosen, J., Ott, J., Adelson, M., & Jeanne Kreek, M. (2014) · Annals of Human Genetics

Neurotransmitter Receptor Influence on BehaviorGenetic Associations and Epidemiology

Cited by 62

Substance-use screening and interventions in dental practices

McNeely, J., Wright, S., Matthews, A. G., Rotrosen, J., Shelley, D., Buchholz, M. P., & Curro, F. A. (2013) · The Journal of the American Dental Association

Substance Abuse Treatment and OutcomesDental Health and Care Utilization

Cited by 39

Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial

O'Donnell, K. C., Mennenga, S. E., Owens, L. T., Podrebarac, S. K., Baron, T., Rotrosen, J., Ross, S., Forcehimes, A. A., & Bogenschutz, M. P. (2022) · Contemporary Clinical Trials

Psychedelics and Drug StudiesSubstance Abuse Treatment and Outcomes

Cited by 23

Genetic variations in genes of the stress response pathway are associated with prolonged abstinence from heroin

Levran, O., Peles, E., Randesi, M., Correa da Rosa, J., Shen, P.-H., Rotrosen, J., Adelson, M., & Kreek, M. J. (2018) · Pharmacogenomics

Opioid Use Disorder TreatmentNeurotransmitter Receptor Influence on Behavior

Cited by 13